期刊文献+

自体血混合曲安奈德、IL-2、利多卡因联合斑秃丸治疗斑秃的疗效 被引量:10

Effect of autologous blood mixed with triamcinolone acetonide,interleukin-2 and lidocaine focal sealing combined with oral administration of Alopecia Areata Pill for treatment of alopecia areata
下载PDF
导出
摘要 目的探讨自体血加曲安奈德、白细胞介素-2(IL-2)、利多卡因局部封闭注射联合斑秃丸治疗斑秃的疗效。方法治疗组62例采用自体血(2mL)加曲安奈德(第1~4周剂量递减,分别为25、20、15、10mg)、IL-2(20万单位)、2%利多卡因(2mL)组成“混合液”皮损处局部封闭注射,每周1次,共4周;对照1组53例采用自体血(2mL)加IL-2(20万单位)、2%利多卡因(2mL)组成“混合液”皮损处局部封闭注射,每周1次,共4周;对照2组51例采用自体血(2mL)加2%利多卡因(2mL)组成“混合液”皮损处局部封闭注射,每周1次,共4周。3组患者均同时给予斑秃丸旱、中、晚各20粒(10g)口服,以4周为1个疗程。结果治疗组痊愈率为54.84%,总有效率为93.55%,对照1组痊愈率为35.85%,总有效率为73.58%,对照2组痊愈率为27.45%,总有效率为54.90%。治疗组和对照1组痊愈率、总有效率比较差异有统计学意义(X2=4.417,P=0.042;X2=8.626,P=0.003);治疗组和对照2组痊愈率、总有效率比较,差异有统计学意义(X2=8.590,P=0.003;X2=22.98,P=0.000);对照1组和对照2组痊愈率比较,差异无统计学意义(X2=0.846,P=0.358),总有效率比较,差异有统计学意义(X2=3.958,P=0.047)。结论自体血加曲安奈德、IL-2、利多卡因局部封闭注射联合斑秃丸治疗斑秃疗效满意,无明显不良反应。 Objective To investigate the autologous blood mixed with triamcinolone acetonide,interleukin-2(IL-2) and lidocaine local sealing combined with oral administration of Alopecia Areata Pill for the treatment of alopecia areata and its effect. Meth- ods The treatment group ( 62 cases) was treated by the mixed solution of autologous blood (2 mL) added with triamcinolone acetonide (doses were decrease progressively to 25,20,15,10 mg) ,IL-2 (20 0000 units) and 2% lidocaine (2 mL) with local sealing at the skin lesion,once per week for 4 weeks. The control group 1 (53 cases) was treated by the mixed solution of autologous blood (2 mL) added with IL-2 (20 0000 units) and 2% lidocaine (2 mL) with local sealing at the skin lesion,once per week for 4 weeks;the control group 2(51 cases) the mixed solution of autologous blood (2 mL) added with and 2% lidocaine (2 mL) with local sealing at the skin lesion, once per week for 4 weeks. The three groups simultaneously took oral Alopecia Areata Pill, each 20 pills at morning,noon and night,with 4 weeks as 1 treatment course. Results The cure rate of the treatment group was 54.84% and the total effective rate was 93.55%, which in the control group 1 and 2 were 35.85%, 73.58% and 27.45 %,54.90% respectively, the cure rate and the total effective rate had statistical difference between the treatment group and the control group 1 (X2=4. 417 ,P= 0. 042 ; X2 = 8. 626 ,P= 0. 003) ;the cure rate and the total effective rate had statistical differences between the treatment group and the control group 2(X2=8. 590,P=0. 003;X2 =22.98,P=0. 000). Conclusion Autologous blood added with triamcinolone acetonide,IL-2 and lidocaine local sealing combined with oral Alopecia Areata Pill for the treatment of alopecia areata has satisfactory effect without obvious adverse reactions. [-
出处 《重庆医学》 CAS 北大核心 2016年第13期1799-1800,共2页 Chongqing medicine
关键词 斑秃 自体血 曲安奈德 白细胞介素-2 利多卡因 斑秃丸 alopeeia areata autologous blood triamcinolone acetonide interleukin-2 lidoeaine alopecia areata pill
  • 相关文献

参考文献10

二级参考文献77

  • 1路永红,周谦.斑秃丸联合胱氨酸治疗斑秃31例疗效分析[J].中国皮肤性病学杂志,2007,21(6):382-383. 被引量:6
  • 2MacDonald Hull SP,Wood ML,Hutchinson PE,et al.Guidelines for the management of alopecia areata.Br J Dermatol,2003,149(4):692-699.
  • 3Olsen EA,Hordinsky MK,Price VH,et al.Alopecia areata investigational assessment guidelinet-Part II.National Alopecia AreataFoundation.J Am Acad Dermatol,2004,51(3):440-447.
  • 4Weiss VC,West DP,Fu TS,et al.Alopecia areata treated with topical minoxidil.Arch Dermatol,1984,120(4):457-463.
  • 5Wasserman D,Guzman-Sanchez DA,Scott K,et al.Alopecia areata.Int J Dermatol,2007,46(2):121-131.
  • 6Kogan EL,Gurbanov FA,Zavgorodniaia EE.Comparative efficacy of steroid drugs in the treatment of all-the-year-round allergic rhinitis.Vestn Otorinolaringol,2006,(6):38-40.
  • 7Alkhalifah A,Alsantali A,Wang E,et al.Alopecia areata update:part II.Treatment.J Am Acad Dermatol,2010,62 (2):191-202,quiz 203-204.
  • 8何慧英 曹毅 马丽俐.斑秃患者白细胞介素2水平和T淋巴细胞亚群观察[J].临床皮肤科杂志,1999,28(2):76-76.
  • 9赵辩.临床皮肤病学[M].3版.南京:江苏科学技术出版社,2001:759-772
  • 10Dubois M, Baumstarck-Barrau K, Gaudy-Marqueste C, et al. Quality of life in alopecia areata: a study of 60 cases[J]. J Invest Dermatol, 2010, 130(12): 2830-2833.

共引文献73

同被引文献114

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部